Snapshot · Russell 3000 · generated 2026-10-15 21:34 UTC

REGN — Regeneron Pharmaceuticals, Inc.

FAIR (MOS +13.6%) · Quality 71/100

REGN - Regeneron Pharmaceuticals, Inc.
Data generated 2026-10-15 21:34 UTC (nightly scan, universe: Russell 3000).
Price: 796.34 USD
Intrinsic value: 921.93 USD
Margin of safety: +13.6%
Implied growth (reverse DCF): +4.5% (model assumes +7.1%)
Valuation: FAIR
Value Score: 34.6
Quality: 71/100
Moat score: 42.5 (erosion: watch)
FAIR (MOS +13.6%) - Quality 71/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/REGN
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

796.34

Intrinsic value

921.93

Margin of safety

+13.6%

Implied growth (reverse DCF)

+4.5%

model assumes +7.1%

Value Score

34.6

Quality

Psychology

-2.7

Discovery

18.4

price/volume attention only

Moat score

42.5

erosion: watch

Value Score: top 43% of Russell 3000 · Quality: top 30%

Dividend: 3.7/share (TTM) · yield 0.5% · payout 9%

Open the interactive Deep Dive for REGN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/REGN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is REGN undervalued?

As of 2026-10-15, REGN trades at 796.34 against a computed intrinsic value of 921.93 (+13.6% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Regeneron Pharmaceuticals, Inc.'s Value Score?

Regeneron Pharmaceuticals, Inc.'s Value Score is 34.6 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does REGN pay a dividend?

Yes - REGN's trailing twelve-month dividend is 3.7/share, a yield of 0.5% at the current price (as of 2026-10-15).